
Histogen HSTO
Histogen ROCE | HSTO
ROCE Jährlich Histogen
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -73.88 | -72.94 | -143.13 | 8.95 | -60.36 | -32.62 | -69.76 | -67.51 | -65.03 | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 8.95 | -143.13 | -64.03 |
ROCE Vierteljährlich Histogen
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -138.73 | -94.67 | -75.51 | -44.91 | -63.05 | -59.05 | -57.18 | -53.88 | -98.82 | -190.62 | -194.21 | -175.29 | -190.66 | -149.15 | -60.19 | -39.79 | -67.82 | -75.26 | -93.48 | -72.5 | -85.45 | -73.18 | -69.33 | -47.67 | -72.11 | -82.46 | -89.9 | -70.93 | -24.44 | -23.29 | -23.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -23.2 | -194.21 | -85.7 |
ROCE anderer Aktien in der Pharmaeinzelhändler
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Celsion Corporation
CLSN
|
-207.46 | - | -6.63 % | $ 13.9 M | ||
|
FSD Pharma
HUGE
|
-299.89 | - | 5743.5 % | $ 69.7 M | ||
|
Qilian International Holding Group Limited
QLI
|
-3.22 | - | -6.08 % | $ 184 M | ||
|
Happiness Biotech Group Limited
HAPP
|
-27.78 | - | 1.35 % | $ 17.8 M | ||
|
Synthetic Biologics
SYN
|
-156.35 | - | 1.32 % | $ 16.2 M | ||
|
Dynavax Technologies Corporation
DVAX
|
-0.69 | - | - | $ 2.02 B | ||
|
BioXcel Therapeutics
BTAI
|
52.86 | $ 1.19 | 5.31 % | $ 14.5 M | ||
|
Burford Capital Limited
BUR
|
9.48 | $ 4.37 | 0.23 % | $ 958 M | ||
|
BeyondSpring
BYSI
|
-213.69 | $ 0.84 | 34.27 % | $ 34.5 M | ||
|
Corner Growth Acquisition Corp.
COOL
|
669.98 | - | -0.89 % | $ 114 M | ||
|
AgeX Therapeutics
AGE
|
64924.32 | - | -10.17 % | $ 12.2 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
17.36 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
-49.48 | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
3539.01 | - | -13.47 % | $ 169 M | ||
|
Cerus Corporation
CERS
|
-13.52 | $ 2.98 | 4.93 % | $ 568 M | ||
|
Compugen Ltd.
CGEN
|
23.38 | $ 2.41 | 4.17 % | $ 225 M | ||
|
CureVac N.V.
CVAC
|
24.32 | - | - | $ 867 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-61.36 | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
-368.0 | - | - | $ 269 M | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
-41.41 | - | 0.74 % | $ 768 M | ||
|
Abcam plc
ABCM
|
-1.18 | - | - | $ 4.9 B | ||
|
Завод ДИОД
DIOD
|
5.84 | - | - | - | ||
|
Galera Therapeutics
GRTX
|
-63.97 | - | -32.59 % | $ 7.61 M | ||
|
Midatech Pharma plc
MTP
|
-71.74 | - | -18.52 % | $ 27.3 M | ||
|
Hepion Pharmaceuticals
HEPA
|
-156.09 | - | -18.79 % | $ 39.3 K | ||
|
ARCA biopharma
ABIO
|
-25.86 | - | 1052.0 % | $ 415 M | ||
|
MorphoSys AG
MOR
|
-14.33 | - | 2.43 % | $ 254 M | ||
|
Champions Oncology
CSBR
|
-28.94 | $ 5.1 | 2.63 % | $ 70.5 M | ||
|
Affimed N.V.
AFMD
|
-149.7 | - | -34.95 % | $ 21.5 M | ||
|
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
766.36 | - | -1.58 % | $ 28.1 M | ||
|
Celyad Oncology SA
CYAD
|
-439.8 | - | - | $ 12.5 M | ||
|
Adial Pharmaceuticals
ADIL
|
-147.82 | $ 3.98 | 1.86 % | $ 2.66 M | ||
|
Generation Bio Co.
GBIO
|
-165.18 | - | - | $ 344 M | ||
|
Akero Therapeutics
AKRO
|
-38.05 | - | - | $ 3.67 B | ||
|
AnaptysBio
ANAB
|
128.72 | $ 58.47 | 4.37 % | $ 1.68 B | ||
|
Anika Therapeutics
ANIK
|
-7.7 | $ 21.5 | 1.56 % | $ 308 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
-123.17 | - | -4.36 % | $ 27 M | ||
|
Gracell Biotechnologies
GRCL
|
-45.4 | - | - | $ 3.37 B | ||
|
Aurinia Pharmaceuticals
AUPH
|
5.72 | $ 15.47 | 1.91 % | $ 2.08 B | ||
|
GlycoMimetics
GLYC
|
-75.18 | - | 9357.83 % | $ 1.01 B | ||
|
Aeterna Zentaris
AEZS
|
-76.42 | - | 5.93 % | $ 314 M | ||
|
AVROBIO
AVRO
|
-33.44 | - | 1083.1 % | $ 745 M | ||
|
BeiGene, Ltd.
BGNE
|
7.03 | - | 0.49 % | $ 251 B | ||
|
Bicycle Therapeutics plc
BCYC
|
-40.5 | $ 3.9 | 0.24 % | $ 270 M | ||
|
Beam Therapeutics
BEAM
|
-30.98 | $ 26.75 | 0.91 % | $ 2.65 B | ||
|
AIkido Pharma
AIKI
|
-80.33 | - | 1.93 % | $ 17.4 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-29.3 | - | - | $ 1.01 B | ||
|
BioMarin Pharmaceutical
BMRN
|
6.73 | $ 67.36 | 0.99 % | $ 12.9 B | ||
|
Aptose Biosciences
APTO
|
-46.69 | - | -45.71 % | $ 1.2 M |